Latest Market Competition News

Infotrust Ltd reported a significant $16.5 million half-year loss driven by a $15.6 million impairment on its Cloud and Communications segment, which it plans to divest for up to $50 million. The move refocuses the company on its core Cyber Security business amid steady revenue growth.

Qualitas Limited has delivered a standout first half of FY26, posting a 30% rise in normalised net profit before tax and record investment deployment, reinforcing its position in Australia’s alternative investment sector.

Pro Medicus has reported its strongest half-year performance yet, with revenue and profits surging alongside a wave of new multi-million dollar contracts and strategic AI investments. The healthcare IT leader is expanding its global footprint and cloud capabilities, setting the stage for sustained growth.

Synertec Corporation Limited has reported a robust 25% increase in revenue for FY26 Q2 alongside a significant turnaround to positive operating cashflow, underpinned by strong project pipelines and strategic partnerships.

Singular Health Group has advanced its U.S. commercial footprint with the deployment of 500 new licences under its PNS contract and secured FDA clearance for its cloud-based 3DICOM MD® platform, positioning the company for significant growth.

Life360 has reported its strongest quarter ever, with record user and subscriber growth in Q4 2025, surpassing full-year revenue and EBITDA guidance. The company forecasts continued momentum with 20% user growth expected in 2026.

EPX Limited has launched a Share Purchase Plan offering eligible shareholders the chance to buy new shares at $0.25 each, matching a recent institutional placement price. The plan aims to raise up to $700,000 to support the company’s growth and working capital needs.

AnteoTech secures a significant order from the Serum Institute of India and expands its Life Sciences pipeline with new product developments and global partnerships, positioning for accelerated growth in 2026.

Weebit Nano has raised its FY26 revenue guidance to a minimum of $10 million following the signing of multiple IP licensing agreements with semiconductor fabs and product companies.

Cann Group Limited has launched a comprehensive suite of option offers aimed at raising incremental capital, subject to shareholder approval at a December 23 meeting. The prospectus outlines potential dilution and financial impacts as the company seeks to strengthen its balance sheet.

Alexium International Group Limited has announced a pro rata non-renounceable rights issue to raise approximately AUD 6.77 million, primarily to repay shareholder loans and finance the acquisition of Microtek Laboratories' microencapsulation business.

Symal Group Limited has announced the acquisition of Timms Group and L&D Contracting, significantly boosting its footprint in Queensland’s civil infrastructure market ahead of the 2032 Brisbane Olympics.